Special Issue "Global Impact of COVID-19 on Stroke Care and Parkinson’s Disease"
Deadline for manuscript submissions: closed (25 July 2023) | Viewed by 4141
Interests: Parkinson's disease; movement disorders
Special Issues, Collections and Topics in MDPI journals
Background: The COVID-19 pandemic has affected the whole world due to an increased risk of mortality and morbidity, especially in vulnerable and at-risk populations. The context of an exponentially increasing number of patients infected with this virus has changed the clinical care of patients with various neurological disorders.
Aim and scope: We aim to publish articles describing a personalized medicine approach to the diagnosis and treatment of patients with stroke and Parkinson’s disease (PD).
History: Huge efforts have been made worldwide in order to offer the best medical care for patients with acute and chronic disorders during the COVID-19 pandemic. Several factors are known to impact the outcome of motor and non-motor symptoms in PD, as well as the evolution of post-stroke patients. The access to acute stroke units is time-dependent and represents a constant challenge. Monitoring patients with Parkinson’s disease which need assistance for current treatment is also challenging.
Cutting-edge research: Current hot topics in clinical practice include risk factors for contracting COVID-19 or for developing PD or stroke after SARS-CoV-2 infection, specific clinical manifestations, the impact on clinical care, the spectrum of long-COVID symptoms, and the role of telemedicine.
We are soliciting submissions of research papers, reviews, and communications for this Special Issue.
Prof. Dr. K. Ray Chaudhuri
Prof. Dr. Cristian Falup-Pecurariu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Parkinson’s disease
- motor symptoms
- non-motor symptoms
- wearable devices
- long-COVID spectrum